Rockefeller Capital Management
WST icon

Rockefeller Capital Management’s West Pharmaceutical WST Stock Holding History

Rockefeller Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Sell
1,397
-954
-41% -$292K ﹤0.01% 2086
2026
Q1 		$589K Buy
2,351
+922
+65% +$229K ﹤0.01% 1877
2025
Q4 		$393K Buy
1,429
+421
+42% +$115K ﹤0.01% 2029
2025
Q3 		$264K Buy
+1,008
New +$245K ﹤0.01% 2080
2023
Q3 		– Sell
-9,106
Closed -$3.48M – 1832
2023
Q2 		$3.48M Buy
9,106
+5,935
+187% +$2.12M 0.01% 683
2023
Q1 		$1.1M Sell
3,171
-255
-7% -$74.5K ﹤0.01% 1032
2022
Q4 		$804K Sell
3,426
-826
-19% -$196K ﹤0.01% 1090
2022
Q3 		$1.04M Sell
4,252
-162
-4% -$49.4K 0.01% 995
2022
Q2 		$1.33M Sell
4,414
-999
-18% -$325K 0.01% 903
2022
Q1 		$2.22M Sell
5,413
-4,003
-43% -$1.57M 0.01% 768
2021
Q4 		$4.42M Sell
9,416
-246
-3% -$106K 0.02% 578
2021
Q3 		$4.1M Buy
9,662
+2,674
+38% +$1.13M 0.02% 534
2021
Q2 		$2.51M Buy
6,988
+3,093
+79% +$1.02M 0.01% 653
2021
Q1 		$1.1M Buy
3,895
+175
+5% +$50.1K 0.01% 753
2020
Q4 		$1.05M Buy
3,720
+2
+0.1% +$561 0.01% 681
2020
Q3 		$1.02M Buy
3,718
+182
+5% +$48.2K 0.01% 592
2020
Q2 		$803K Buy
3,536
+1,889
+115% +$371K 0.01% 588
2020
Q1 		$251K Buy
1,647
+1,599
+3,331% +$246K ﹤0.01% 767
2019
Q4 		$7K Buy
+48
New +$6.99K ﹤0.01% 1719
2019
Q2 		– Sell
-326
Closed -$36K – 2017
2019
Q1 		$36K Buy
+326
New +$33.9K ﹤0.01% 1019

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Rockefeller Capital Management's WST Position: Q2 2026 in Review

Rockefeller Capital Management reduced its West Pharmaceutical (WST) stake by 41% in Q2 2026, selling an estimated $292K and leaving 1,397 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

Rockefeller Capital Management first reported a position in WST in Q1 2019 and has held it in 20 quarters since. The position peaked at $4.42M in Q4 2021. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Rockefeller Capital Management held 1,397 shares of West Pharmaceutical worth $502K as of Q2 2026.
  • Rockefeller Capital Management sold 954 West Pharmaceutical shares in Q2 2026, an estimated $292K.
  • West Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2086 holding.
  • Rockefeller Capital Management first reported a position in West Pharmaceutical in Q1 2019 and has held it in 20 quarters since.
  • Rockefeller Capital Management's West Pharmaceutical position peaked at $4.42M in Q4 2021.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.